A new heterozygous mutation in gamma fibrinogen gene leading to 326 Cys→Ser substitution in fibrinogen Córdoba is associated with defective polymerization and familial hypodysfibrinogenemia [4]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 352-354

  Guglielmone, Hugo A ^a   Sanchez, M C ^a   Abate Daga, D ^a   Bocco, J L ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; FIBRINOGEN; FIBRINOGEN VARIANT;

ADULT; AMINO ACID SUBSTITUTION; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; CASE REPORT; CRYOPRECIPITATION; DISULFIDE BOND; DNA ISOLATION; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC HETEROGENEITY; HUMAN; HYPOFIBRINOGENEMIA; LETTER; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TOOTH EXTRACTION; FAMILY HEALTH; GENETICS; HETEROZYGOTE; MIDDLE AGED; PEDIGREE; POINT MUTATION;

AMINO ACID SUBSTITUTION; BLOOD COAGULATION DISORDERS; FAMILY HEALTH; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION;

EID: 4644356290     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.0584d.x     Document Type: Letter

References (11)

1. Menache D. Constitutional and familial abnormal fibrinogen. Thromb Haemost 1964; 13: 173-6.
2. Martinez J. Quantitative and qualitative disorders of fibrinogen. In: Hoffmann R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds. Hematology, Basic Principles and Practice, 3rd edn. New York: Churchill Livingstone, 2000: 1924-36.
3. Caté HC, Lord ST, Pratt KP. Gamma chain dysfibrinogenemia: molecular structure-function relationship of naturally occurring mutations in the gamma-chain of human fibrinogen. Blood 1998; 92 2195-212.
4. Guglielmone HA, Sánchez MC, Quiñonez M, Fernandez EJ. Fibrinogen Córdoba: biochemical characterization of a new congenital hypodysfibrinogenemia. Clin Chim Acta 2002; 317: 239-40.
5. Sambrook J, Fritsch EF, Maniatis T. Analysis and cloning of eukaryotic genomic DNA. In: Molecular Cloning. A Laboratory Manual, Vol. 2, 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989; 9: 16-19.
6. Imafuku Y, Tanaka K, Takahashi K, Ogawa K, Samper M, Yamada J, Sato A, Yoshida M. Identification of a dysfibrinogenemia of γ R275C (Fibrinogen Fukushima). Clin Chim Acta 2002; 325: 151-6.
7. Spraggon G, Everse S, Doolittle R. Crystal structure of fragment D from human fibrinogen and its crosslink counterpart from fibrin. Nature 1997; 389: 455-62.
8. Procyk R, Medved L, Engelke K, Kudryle B, Blomback B. Nonclottable fibrin obtained from partially reduced fibrinogen: characterization and tissue plasminogen activator stimulation. Biochemistry 1992; 31: 2273-8.
9. Doolittle R, Spraggon G, Everse S. Three-dimensional structural studies on fragments of fibrinogen and fibrin. Curr Opin Struct Biol 1998; 8: 792-8.
10. Bonifacio JS, Weissman AM. Ubiquitin and the control of protein fate in the secretory and endocytic pathway. Ann Rev Cell Dev Biol 1998; 14: 19-57.
11. Redman CM, Xia H. Fibrinogen biosynthesis. Assembly, intracellular degradation, association with lipid synthesis and secretion. Ann N Y Acad Sci 2001; 936: 480-95.